Imagine some teeny-tiny little scissors. Now, imagine them snipping out "bad" genes that cause disease, and leaving only the good ones behind. Sound farfetched? Well, actually, it is not. In fact, that's exactly what they're doing at Cleveland Clinic Children's, where a Sickle Cell Disease clinical trial involving CRSPR gene editing…